Volume 30, Number 1—January 2024
Research
Incidence of Legionnaires’ Disease among Travelers Visiting Hotels in Germany, 2015–2019
Table 2
Constellation | No. | TALD cases/1 million nights | IRR (95% CI) |
---|---|---|---|
First-case incidence rate† | |||
No. nights in hotels in Germany during 2015−2019 | 1,351,540,219 | NA | NA |
No. nights from first TALD case until end of 2019 | 24,568,957 | NA | NA |
No. nights in hotels that did not have a TALD case or until occurrence of first case | 1,326,971,262 | NA | NA |
No. hotels that had a first TALD case | 309 | NA | NA |
First-case incidence |
NA |
0.23 |
Referent |
Second-case incidence rate among hotels that had a first case | |||
No. nights among hotels that had a first case before the end of 2019 or until the occurrence of a second case | 21,905,432 | NA | NA |
No. hotels that had a second TALD case | 28 | NA | NA |
Second-case incidence |
NA |
1.3 |
5.5 (3.6−7.9) |
Third-case incidence rate among hotels that had a second case | |||
No. nights among hotels that had a second case before the end of 2019 or until the occurrence of a third case | 1,274,759 | NA | NA |
No. hotels that had a third TALD case | 12 | NA | NA |
Third-case incidence |
NA |
9.4 |
40 (21−71) |
Third-case incidence rate among cluster or reoffending hotels | |||
No. nights among cluster hotels before the end of 2019 or until the occurrence of a third case >8 wk after cluster notification | 1,350,676 | NA | NA |
No. reoffending hotels that had a third TALD case | 8 | NA | NA |
Reoffender incidence | NA | 5.9 | 25 (11−50) |
*Data were reported by 29 countries (including Germany) to the European Legionnaires’ Disease Surveillance Network (https://www.ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/eldsnet); numbers of nights are provided for travelers of those 29 countries. IRR, incidence rate ratio; NA, not applicable; TALD, travel-associated Legionnaires’ disease. †Baseline/referent incidence rate among all hotels.
Page created: October 31, 2023
Page updated: December 22, 2023
Page reviewed: December 22, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.